Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel B. Soland currently holds 9,387 shares of ACADIA PHARMACEUTICALS INC (ACAD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel B. Soland has been a net buyer of ACAD stock. They have purchased $1.2M and sold $989.7K worth of shares.
Daniel B. Soland's most recent insider trade was on May 29, 2024, when they sold 6,652 shares at $0.00 per share.
Daniel B. Soland serves as Executive at ACADIA PHARMACEUTICALS INC (ACAD). They have executed 45 insider transactions totaling $2.1M over their tenure at the company.
Daniel B. Soland holds the position of Executive at ACADIA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Daniel B. Soland has shown a buying trading pattern, with $1.2M in total purchases and $989.7K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Daniel B. Soland was on Jan 24, 2014, when they sold $7.7M worth of VPHM shares. This transaction involved 153,332 shares at $50.00 per share.
Daniel B. Soland currently owns 9,387 shares of ACADIA PHARMACEUTICALS INC (ACAD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel B. Soland's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel B. Soland has 45 Form 4 filings on record as an insider at ACADIA PHARMACEUTICALS INC.
Set alerts for Daniel B. Soland and 40,000+ other insiders.